TSN
38
-2
KR
59
10
ECL
84
2
RL
76
3
PEG
55
2
CMA
52
2
JCI
44
2
UA
35
-13
GOOGL
61
-11
CHK
39
19
NVDA
60
-3
MCD
46
-3
MU
56
-3
EQT
57
3
ZION
55
2
HUM
43
-4
CAH
43
2
VLO
45
6
SCHW
58
2
CSX
39
-4
TSN
38
-2
KR
59
10
ECL
84
2
RL
76
3
PEG
55
2
CMA
52
2
JCI
44
2
UA
35
-13
GOOGL
61
-11
CHK
39
19
NVDA
60
-3
MCD
46
-3
MU
56
-3
EQT
57
3
ZION
55
2
HUM
43
-4
CAH
43
2
VLO
45
6
SCHW
58
2
CSX
39
-4
Financhill
Back

Enlivex Therapeutics Vs. BioLine Rx Industry Stock Comparison

Buy
69

ENLV
Enlivex Therapeutics

Last Price:
1.41
Seasonality Move:
15%
Sell
44

BLRX
BioLine Rx

Last Price:
0.64
Seasonality Move:
4.13%
Buy
69
Enlivex Therapeutics (ENLV) is a Buy

Is Enlivex Therapeutics a Buy, Sell or Hold?

  • The current Enlivex Therapeutics [ENLV] share price is $1.41. The Score for ENLV is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ENLV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.64. The Score for BLRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENLV Stock Price Chart

What is Enlivex Therapeutics's stock price today?

  • The Enlivex Therapeutics share price today is $1.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight selling pressure.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.

ENLV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 31.86 Sell
Chaikin Money Flow: -11938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.37 - 1.59) Sell
Bollinger Bands (100): (1.89 - 3.75) Sell

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.89 Sell
Chaikin Money Flow: -47980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.62 - 0.68) Sell
Bollinger Bands (100): (0.76 - 1.38) Sell

ENLV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.46 Sell
20-day SMA: 1.5 Sell
50-day SMA: 2.65 Sell
200-day SMA: 2.35 Sell
8-day EMA: 1.46 Sell
20-day EMA: 1.65 Sell
50-day EMA: 2.19 Sell
200-day EMA: 2.59 Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Sell
20-day SMA: 0.65 Sell
50-day SMA: 0.83 Sell
200-day SMA: 1.34 Sell
8-day EMA: 0.64 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.81 Sell
200-day EMA: 1.17 Sell

Enlivex Therapeutics Earnings Growth & ENLV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.50 per share, and an increase next year of $0.31 per share.

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.10 per share.

Enlivex Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):